1.44
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.44
loading
Schlusskurs vom Vortag:
$1.44
Offen:
$1.45
24-Stunden-Volumen:
71,791
Relative Volume:
2.03
Marktkapitalisierung:
$37.88M
Einnahmen:
$9.06M
Nettoeinkommen (Verlust:
$-50.39M
KGV:
-0.75
EPS:
-1.92
Netto-Cashflow:
$5.89M
1W Leistung:
+2.86%
1M Leistung:
+9.92%
6M Leistung:
+52.66%
1J Leistung:
-28.71%
1-Tages-Spanne:
Value
$1.40
$1.57
1-Wochen-Bereich:
Value
$1.39
$1.57
52-Wochen-Spanne:
Value
$0.8502
$2.21

Lava Therapeutics Nv Stock (LVTX) Company Profile

Name
Firmenname
Lava Therapeutics Nv
Name
Telefon
31 6 3000 3035
Name
Adresse
YALELAAN 62, UTRECHT
Name
Mitarbeiter
34
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-28
Name
Neueste SEC-Einreichungen
Name
LVTX's Discussions on Twitter

Vergleichen Sie LVTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LVTX
Lava Therapeutics Nv
1.44 36.83M 9.06M -50.39M 5.89M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-12 Herabstufung Leerink Partners Outperform → Market Perform
2024-12-11 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2022-10-25 Eingeleitet H.C. Wainwright Buy
2021-04-19 Eingeleitet JP Morgan Overweight
2021-04-19 Eingeleitet Jefferies Buy
2021-04-19 Eingeleitet SVB Leerink Outperform
Alle ansehen

Lava Therapeutics Nv Aktie (LVTX) Neueste Nachrichten

pulisher
Jul 22, 2025

AgEagle Aerial Systems Inc. Stock Analysis and ForecastSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about LAVA Therapeutics N.V. stockConsistent wealth multiplication - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Personalis Inc. Stock Analysis and ForecastMassive stock growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Sigachi Industries Limited (SIGACHI) Announces Strategic ShiftFree Trading Psychology Coaching - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What drives LAVA Therapeutics N.V. stock priceRapid growth opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is Universal Corporation a good long term investmentSuperior trading gains - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Best Mid Cap Growth Stocks Elite Trader Market TipsPhenomenal trading returns - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

LAVA Therapeutics N.V. Stock Analysis and ForecastRapid growth trajectories - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

TruCap Finance Limited (TRU) Hits 52 Week HighPowerful profit generation - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

Waaree Energies Limited (544277) Quarterly Results Are OutFree Predictions - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about ACCO stockRobust investment performance - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Nucor Corporation stock priceFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

P500 stockConsistent triple returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is LAVA Therapeutics N.V. a good long term investmentFree Stock Movement Tracking - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What analysts say about SARO stockExceptional earning trajectories - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What drives ARGD stock priceExplosive wealth accumulation - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

How LAVA Therapeutics N.V. stock performs during market volatilityLow Volatility High Yield Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why LAVA Therapeutics N.V. stock attracts strong analyst attentionHigh Return Setup Scanner - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Hurco Companies Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes LAVA Therapeutics N.V. stock price move sharplyMassive Gain Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How C PROCL stock performs during market volatilityFree Stock Market Forums - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Earning from Blockchain Based Digital Wallet ServicesFree Deep Market Trend Analysis - Newser

Jul 15, 2025
pulisher
Jun 13, 2025

LAVA Therapeutics Shareholders Approve Key Proposals in Meeting - TipRanks

Jun 13, 2025
pulisher
May 19, 2025

LAVA Therapeutics NV reports results for the quarter ended March 31Earnings Summary - TradingView

May 19, 2025
pulisher
May 16, 2025

Here's Why We're Watching LAVA Therapeutics' (NASDAQ:LVTX) Cash Burn Situation - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

LAVA Therapeutics (LVTX) Receives Reiterated Market Perform Rati - GuruFocus

May 15, 2025
pulisher
May 14, 2025

LAVA Reports First Quarter 2025 Financial Results, Provides Business Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

LAVA (LVTX) Pursues Strategic Moves Amid Workforce Restructuring - GuruFocus

May 14, 2025
pulisher
May 14, 2025

LAVA Therapeutics Slashes 30% Workforce, Closes Netherlands Operations Amid Strategic Review - Stock Titan

May 14, 2025
pulisher
Apr 30, 2025

RNA Editing Market Deep Research 2025-2032 | QIAGEN N.V., ProQR - openPR.com

Apr 30, 2025
pulisher
Apr 16, 2025

LAVA Therapeutics Strengthens Balance Sheet with $5.1 Million Repayment Waiver from Netherlands Enterprise Agency - Nasdaq

Apr 16, 2025
pulisher
Apr 16, 2025

Lava Therapeutics Granted Full Waiver For RVO Payment Obligation - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

LAVA Therapeutics Strengthens Balance Sheet: Secures Complete Waiver of $5.1M Debt - Stock Titan

Apr 16, 2025
pulisher
Apr 06, 2025

Investors Aren't Buying LAVA Therapeutics N.V.'s (NASDAQ:LVTX) Revenues - simplywall.st

Apr 06, 2025
pulisher
Apr 01, 2025

Lava Therapeutics’ SWOT analysis: biotech stock faces crossroads after asset cut - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

LAVA Therapeutics (NASDAQ:LVTX) Receives Neutral Rating from HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Leerink cuts Lava Therapeutics stock target to $1 By Investing.com - Investing.com Canada

Mar 31, 2025

Finanzdaten der Lava Therapeutics Nv-Aktie (LVTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):